• Return to Headlines

Highest Forward P/E Ratio in the Pharmaceuticals Industry Detected in Shares of Pacira Pharmaceu (PCRX, ZTS, CTLT, LLY, COLL)

By Nick Russo

Below are the three companies in the Pharmaceuticals industry with the highest forward price to earnings (P/E) ratios. Forward P/E uses estimated earnings to compare relative value among companies in the same industry. Generally, the lower the forward P/E, the more undervalued a company is believed to be.

Pacira Pharmaceu ranks highest with a a forward P/E ratio of 40.16. Following is Zoetis Inc with a a forward P/E ratio of 35.69. Catalent Inc ranks third highest with a a forward P/E ratio of 28.97.

Eli Lilly & Co follows with a a forward P/E ratio of 19.91, and Collegium Pharma rounds out the top five with a a forward P/E ratio of 18.66.

SmarTrend is monitoring the recent change of momentum in Eli Lilly & Co. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Eli Lilly & Co in search of a potential trend change.

Keywords: highest forward p/e ratio pacira pharmaceu zoetis inc catalent inc eli lilly & co collegium pharma

Ticker(s): PCRX ZTS CTLT LLY COLL